chr19-7205229-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000208.4(INSR):c.653-20592G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.184 in 152,208 control chromosomes in the GnomAD database, including 2,893 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.18   (  2893   hom.,  cov: 33) 
Consequence
 INSR
NM_000208.4 intron
NM_000208.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.644  
Publications
13 publications found 
Genes affected
 INSR  (HGNC:6091):  (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015] 
INSR Gene-Disease associations (from GenCC):
- insulin-resistance syndrome type AInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
 - Donohue syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
 - hyperinsulinism due to INSR deficiencyInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
 - Rabson-Mendenhall syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83). 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.225  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| INSR | NM_000208.4  | c.653-20592G>A | intron_variant | Intron 2 of 21 | ENST00000302850.10 | NP_000199.2 | ||
| INSR | NM_001079817.3  | c.653-20592G>A | intron_variant | Intron 2 of 20 | NP_001073285.1 | |||
| INSR | XM_011527988.3  | c.653-20592G>A | intron_variant | Intron 2 of 21 | XP_011526290.2 | |||
| INSR | XM_011527989.4  | c.653-20592G>A | intron_variant | Intron 2 of 20 | XP_011526291.2 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| INSR | ENST00000302850.10  | c.653-20592G>A | intron_variant | Intron 2 of 21 | 1 | NM_000208.4 | ENSP00000303830.4 | |||
| INSR | ENST00000341500.9  | c.653-20592G>A | intron_variant | Intron 2 of 20 | 1 | ENSP00000342838.4 | ||||
| INSR | ENST00000598216.1  | n.628-20592G>A | intron_variant | Intron 2 of 9 | 1 | 
Frequencies
GnomAD3 genomes   AF:  0.184  AC: 28016AN: 152090Hom.:  2891  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
28016
AN: 
152090
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.184  AC: 28031AN: 152208Hom.:  2893  Cov.: 33 AF XY:  0.185  AC XY: 13768AN XY: 74412 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
28031
AN: 
152208
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
13768
AN XY: 
74412
show subpopulations 
African (AFR) 
 AF: 
AC: 
3818
AN: 
41554
American (AMR) 
 AF: 
AC: 
3326
AN: 
15278
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
767
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
399
AN: 
5172
South Asian (SAS) 
 AF: 
AC: 
946
AN: 
4824
European-Finnish (FIN) 
 AF: 
AC: 
2637
AN: 
10584
Middle Eastern (MID) 
 AF: 
AC: 
56
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
15539
AN: 
68008
Other (OTH) 
 AF: 
AC: 
420
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 1166 
 2331 
 3497 
 4662 
 5828 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 306 
 612 
 918 
 1224 
 1530 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
554
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.